Skip to main content
Close

Fraser Valley Centre

If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.

Tumour Group / Site Trial Title Opening Date





BreastAn Open-Label,Multicenter,Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination with Letrozole for the Treatment of Men and Postmenopausal Women with Hormone Receptor-Positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC)with No Prior Hormonal Therapy for Advanced Disease CLEE011A2404 (CompLEEment-1)June 2017
GUAndrogen Suppression with Stereotactic Body or External Beam Radiation Therapy-A Phase II Randomized Trial for Intermediate and High Risk Prostate Cancer (ASSERT)June 2016
GUATLAS, A Randomized, Double-Blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy (ATLAS)Sept 2016
GYNEA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy (PRIMA)
LungA Phase 3 Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant Medi4736 in Completely Resected Non-Small Cell Lung Cancer (BR31)Sept 2015
LungA Phase II Randomized Study of 
Pembrolizumab in Patients with Advanced Malignant Pleural 
Mesothelioma (IND 227)
Feb 2017
Lymphoma

A Phase 2, Multicenter, Multi-Cohort, Open-Label Study of Pomalidomide in Combination with Low Dose Dexamethasone or Pomalidomide in Combination with Low-Dose Dexamethasone and Daratumumab in Subjects with Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based therapy in the First or Second Line Setting (CC-4047-MM-014)

July 2017
LymphomaBiology of Lymphoid Cancer (Lymphoid Study)Jan 2014
​Melanoma

A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)

ME.13


July 2017
 You can view a video on participating in clinical trials that was created by staff at BC Cancer Agency's Fraser Valley Centre.
http://learn.phsa.ca/bcca/clinicaltrials/2012oct23/ClinicalTrials2012oct23_flv_loader.html

SOURCE: Fraser Valley Centre ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer Agency. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority